Moderna stock slides 14% premarket after profit and revenue fall short of estimates and biotech offers soft guidance
Moderna Inc. shares MRNA, -3.88% slid 14% in premarket trade Thursday, after the COVID vaccine…
Read MoreModerna Inc. shares MRNA, -3.88% slid 14% in premarket trade Thursday, after the COVID vaccine…
Read MoreThe omicron sublineages named BQ.1 and BQ.1.1 continued to spread in the U.S. in the…
Read MoreThe omicron sublineages named BQ.1 and BQ.1.1 continued to spread in the U.S. in the…
Read MoreThe Centers for Disease Control and Prevention has refuted claims that it’s planning to add…
Read MoreThe Centers for Disease Control and Prevention has refuted claims that it’s planning to add…
Read MorePfizer Inc. PFE, +3.06% said Thursday that it plans to sell the COVID-19 shot it…
Read MorePfizer Inc. PFE, +4.67% said Thursday that it plans to sell the COVID-19 shot it…
Read MoreAnother omicron subvariant was determined to have spread to more countries in the week through…
Read MoreAnother omicron subvariant was determined to have spread to more countries in the week through…
Read More
Wall Street is being nicer on earnings as vaccine makers, fintech reports near
With a downcast earnings season passing the halfway mark, results from financial-technology and vaccine makers…
Read More